After a @-month run-in period using twice-daily insulin glargine ( or usual basal insulin therapy for pump users ) with prandial lispro , @ subjects with T@D ( @ @ years ; body mass index : @ @ kg/m ( @ ) ; A@c : @ @ % ) were assigned to INSULIN-PH@ or lispro in a random sequence for two consecutive , @-week periods as the prandial insulin in an intensive treatment regimen .